The fact that all the prostate tumors are enriched for deletion of the entire locus or for deletion of both FoxP1 and Shq1, rather than selective deletion of FoxP1 and/or Shq1 individually, suggests that at least two genes in the interval play a role in restraining tumor progression in this model. The gene discussed is FOXP1; the disease is neoplasm.